CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In CML however, compared to normal HSCs, chronic phase CD34+ cells have increased expression of BMI1 and the levels continue to increase with disease severity through accelerated phase and blast phase, with high expression levels correlating with poor prognosis (Mohty et al., 2007; Saudy et al., 2014).